View Financial HealthCore Scientific 配当と自社株買い配当金 基準チェック /06Core Scientific配当金を支払った記録がありません。主要情報n/a配当利回り0.5%バイバック利回り総株主利回り0.5%将来の配当利回り0%配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • May 27Core Scientific, Inc. Appoints Steve Smith to Its Board of Directors and Nominating and Corporate Governance Committee, Effective May 26, 2026Core Scientific, Inc. announced the appointment of Steve Smith to its Board of Directors, effective May 26, 2026. Mr. Smith will also serve on the Company’s Nominating and Corporate Governance Committee. Mr. Smith, age 70, brings over 35 years of leadership experience in the data center, digital infrastructure and technology industries. He is currently Chief Executive Officer of Zayo Group, a global internet network provider since 2020. Previously, Mr. Smith served as CEO and President of Equinix from 2007 to 2018, where he led the company in scaling annual revenue from approximately $400 million to more than $4 billion and oversaw the successful integration of more than 20 acquisitions. Prior to Equinix, Mr. Smith held senior leadership roles at HP Services, Lucent Technologies and Electronic Data Systems Corporation. Mr. Smith currently serves on the boards of directors of Zayo and NEXTDC, a publicly traded Australian data center company. He graduated from the U.S. Military Academy at West Point with a Bachelor of Science in Engineering.Breakeven Date Change • May 11Forecast breakeven date pushed back to 2027The 13 analysts covering Core Scientific previously expected the company to break even in 2026. New consensus forecast suggests losses will reduce by 6.5% to 2026. The company is expected to make a profit of US$229.2m in 2027. Average annual earnings growth of 109% is required to achieve expected profit on schedule.Reported Earnings • May 07First quarter 2026 earnings released: US$1.08 loss per share (vs US$0.17 loss in 1Q 2025)First quarter 2026 results: US$1.08 loss per share (further deteriorated from US$0.17 loss in 1Q 2025). Revenue: US$115.2m (up 45% from 1Q 2025). Net loss: US$347.2m (loss widened US$293.5m from 1Q 2025). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Italy.お知らせ • Apr 26Core Scientific, Inc. to Report Q1, 2026 Results on May 06, 2026Core Scientific, Inc. announced that they will report Q1, 2026 results After-Market on May 06, 2026お知らせ • Apr 01Core Scientific, Inc., Annual General Meeting, May 12, 2026Core Scientific, Inc., Annual General Meeting, May 12, 2026.Reported Earnings • Mar 03Full year 2025 earnings released: US$0.91 loss per share (vs US$4.39 loss in FY 2024)Full year 2025 results: US$0.91 loss per share (improved from US$4.39 loss in FY 2024). Revenue: US$319.0m (down 38% from FY 2024). Net loss: US$288.6m (loss narrowed 74% from FY 2024). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in Italy.お知らせ • Mar 03Core Scientific, Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2025Core Scientific, Inc. reported impairment of property, plant and equipment of $11,359,000 for the fourth quarter ended December 31, 2025 against $25,608,000 a year ago.お知らせ • Feb 23Core Scientific, Inc. to Report Q4, 2025 Results on Mar 02, 2026Core Scientific, Inc. announced that they will report Q4, 2025 results After-Market on Mar 02, 2026お知らせ • Feb 20Core Scientific, Inc. Announces Jordan Levy Notifies That He Will Not Stand for Re-Election as Chairman of the Board of DirectorsOn February 18, 2026, Jordan Levy, the Chairman of the Board of Directors, notified the Core Scientific, Inc. and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. His decision not to stand for re-election is not due to any disagreement with the Company.Board Change • Nov 25High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Eric Weiss is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.決済の安定と成長配当データの取得安定した配当: 1CORZの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 1CORZの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Core Scientific 配当利回り対市場1CORZ 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (1CORZ)n/a市場下位25% (IT)1.6%市場トップ25% (IT)4.6%業界平均 (Software)2.0%アナリスト予想 (1CORZ) (最長3年)0%注目すべき配当: 1CORZは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 1CORZは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 1CORZの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: 1CORZが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YIT 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/25 19:23終値2026/06/25 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Core Scientific, Inc. 17 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。23 アナリスト機関Andrew Charles BealeArete Research Services LLPRamsey El-AssalBarclaysGautam ChhuganiBernstein20 その他のアナリストを表示
お知らせ • May 27Core Scientific, Inc. Appoints Steve Smith to Its Board of Directors and Nominating and Corporate Governance Committee, Effective May 26, 2026Core Scientific, Inc. announced the appointment of Steve Smith to its Board of Directors, effective May 26, 2026. Mr. Smith will also serve on the Company’s Nominating and Corporate Governance Committee. Mr. Smith, age 70, brings over 35 years of leadership experience in the data center, digital infrastructure and technology industries. He is currently Chief Executive Officer of Zayo Group, a global internet network provider since 2020. Previously, Mr. Smith served as CEO and President of Equinix from 2007 to 2018, where he led the company in scaling annual revenue from approximately $400 million to more than $4 billion and oversaw the successful integration of more than 20 acquisitions. Prior to Equinix, Mr. Smith held senior leadership roles at HP Services, Lucent Technologies and Electronic Data Systems Corporation. Mr. Smith currently serves on the boards of directors of Zayo and NEXTDC, a publicly traded Australian data center company. He graduated from the U.S. Military Academy at West Point with a Bachelor of Science in Engineering.
Breakeven Date Change • May 11Forecast breakeven date pushed back to 2027The 13 analysts covering Core Scientific previously expected the company to break even in 2026. New consensus forecast suggests losses will reduce by 6.5% to 2026. The company is expected to make a profit of US$229.2m in 2027. Average annual earnings growth of 109% is required to achieve expected profit on schedule.
Reported Earnings • May 07First quarter 2026 earnings released: US$1.08 loss per share (vs US$0.17 loss in 1Q 2025)First quarter 2026 results: US$1.08 loss per share (further deteriorated from US$0.17 loss in 1Q 2025). Revenue: US$115.2m (up 45% from 1Q 2025). Net loss: US$347.2m (loss widened US$293.5m from 1Q 2025). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Italy.
お知らせ • Apr 26Core Scientific, Inc. to Report Q1, 2026 Results on May 06, 2026Core Scientific, Inc. announced that they will report Q1, 2026 results After-Market on May 06, 2026
お知らせ • Apr 01Core Scientific, Inc., Annual General Meeting, May 12, 2026Core Scientific, Inc., Annual General Meeting, May 12, 2026.
Reported Earnings • Mar 03Full year 2025 earnings released: US$0.91 loss per share (vs US$4.39 loss in FY 2024)Full year 2025 results: US$0.91 loss per share (improved from US$4.39 loss in FY 2024). Revenue: US$319.0m (down 38% from FY 2024). Net loss: US$288.6m (loss narrowed 74% from FY 2024). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in Italy.
お知らせ • Mar 03Core Scientific, Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2025Core Scientific, Inc. reported impairment of property, plant and equipment of $11,359,000 for the fourth quarter ended December 31, 2025 against $25,608,000 a year ago.
お知らせ • Feb 23Core Scientific, Inc. to Report Q4, 2025 Results on Mar 02, 2026Core Scientific, Inc. announced that they will report Q4, 2025 results After-Market on Mar 02, 2026
お知らせ • Feb 20Core Scientific, Inc. Announces Jordan Levy Notifies That He Will Not Stand for Re-Election as Chairman of the Board of DirectorsOn February 18, 2026, Jordan Levy, the Chairman of the Board of Directors, notified the Core Scientific, Inc. and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. His decision not to stand for re-election is not due to any disagreement with the Company.
Board Change • Nov 25High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Eric Weiss is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.